View of Evalution of glucose lowering efficacy between Dipeptidyl Peptidase-4 inhibitors (DPP-4) and Sodium-Glucose cotransporter-2 inhibitors (SGLT-2) in type 2 diabetes mellitus patients at Hospital

Return to Article Details Evalution of glucose lowering efficacy between Dipeptidyl Peptidase-4 inhibitors (DPP-4) and Sodium-Glucose cotransporter-2 inhibitors (SGLT-2) in type 2 diabetes mellitus patients at Hospital Download Download PDF